Lyophilization, also called freeze-drying, is a process that removes water from a product by freezing it and then turning the ice directly into vapour under a vacuum. Many peptides are supplied as a lyophilized powder because they are usually more stable dry than dissolved in water. But freeze-drying is not magic. It introduces its own stresses, and a dried peptide still needs protection from heat, light and moisture.
This guide explains how lyophilization works, why it is so widely used for peptides, and what its limits are.
Key Takeaways
- Lyophilization has three main stages: freezing, primary drying and secondary drying [1].
- It is common practice for synthetic peptides and a standard way to give proteins an acceptable shelf life [2][3].
- Freezing and drying both stress delicate molecules, so good formulation and process design matter [3].
- A small amount of water always remains, and the right level affects stability [4].
- Dried peptides are often hygroscopic (moisture-absorbing), so packaging and storage still matter [2].
What Does Lyophilization Mean?
In practice, lyophilization describes a very specific way of drying:
- The product is frozen, so the water turns into ice.
- The pressure is lowered to form a vacuum.
- Gentle heat is applied so that the ice sublimes, meaning it turns directly from solid to vapour without melting into liquid.
Because the water leaves as vapour from a frozen structure, the product keeps a porous, sponge-like shape. The dried result is often called a cake.
Why Are Peptides Lyophilized?
Water drives many degradation reactions
Peptides in solution are exposed to chemical reactions such as hydrolysis (breakdown by water), deamidation and oxidation. A 2023 review of therapeutic peptides notes that peptides are often unstable in aqueous solutions and that a dry formulation designed for reconstitution is one way around this [5]. For proteins, a major review describes making them into solid forms as often necessary to achieve an acceptable shelf life, with lyophilization the most common method [3]. For more on these reactions, see how peptides degrade.
It is standard practice for synthetic peptides
The European Medicines Agency's guideline on synthetic peptides states that lyophilisation of synthetic peptides is considered common practice, while other isolation methods such as precipitation, crystallisation and spray drying are also used [2]. (This is an EU guideline for medicines, applicable since 1 June 2026; other jurisdictions set their own requirements.)
It is gentler than heat drying
Ordinary drying with heat could damage heat-sensitive molecules. Freeze-drying removes water at low temperatures, which is why it is widely used for biological materials.
The Three Stages of Lyophilization
| Stage | What happens | Key concern |
|---|---|---|
| 1. Freezing | The solution is cooled until water forms ice crystals; the peptide and other ingredients are concentrated between the crystals | Ice formation affects the structure of the final cake and how easily it dries |
| 2. Primary drying | Under vacuum, gentle heat makes the ice sublime | The product must stay below a critical temperature or the structure can collapse |
| 3. Secondary drying | Temperature is raised to remove water that is bound to the solid, rather than frozen as ice | Reaching an appropriate residual moisture level |
Stage 1: Freezing
Freezing may look simple, but it shapes everything that follows. How ice nucleates and grows affects the rest of the process and the final product quality [1]. As water freezes out, the remaining liquid becomes highly concentrated, which can itself stress the molecules.
Stage 2: Primary drying
During this stage, scientists pay close attention to two related properties:
- Tg′ (glass transition temperature of the freeze-concentrate): the temperature at which the concentrated, non-frozen part of the frozen material changes from a rigid glass to a softer state.
- Collapse temperature: the temperature above which the drying structure can lose its shape and collapse.
A well-designed cycle picks a target product temperature that stays safely below these limits while still drying efficiently [1].
Stage 3: Secondary drying
Even after the ice is gone, some water remains attached to the solid. Secondary drying removes much of this bound water. Guidelines for optimising this step are part of good process design [1].
Freeze-Drying Is Not Stress-Free
Lyophilization protects peptides in storage, but the process itself creates freezing stresses and drying stresses that can damage delicate molecules to varying degrees [3]. For peptides, physical stability is also a concern. A review from the University of Cambridge lists lyophilization among the physical factors, along with temperature, pressure and agitation, that can influence peptide aggregation (clumping) [6].
To reduce these stresses, formulators often add excipients (inactive ingredients). Some act as:
- Cryoprotectants, which help protect molecules during freezing.
- Lyoprotectants, such as certain sugars, which help protect molecules during drying and in the dried state [4].
Reviews of lyophilized protein formulations discuss how these ingredients are chosen and why rational design matters [3][7].
Residual Moisture: Drier Is Not Always Simpler
It is tempting to think that the drier a product is, the better. The reality is more nuanced. In one study of a lyophilized antibody formulation, stability data suggested a minimum in degradation rate at about 2–3% water content, rather than at the lowest possible moisture [4]. That result was for one specific protein formulation and should not be generalised to all peptides. The key point is that residual moisture is a quality parameter that manufacturers measure and control, not something to guess.
For hygroscopic peptide powders, the EMA expects water content to be included in stability studies, and suggests desiccants or storage under an inert atmosphere may be considered for packaging [2].
What Lyophilization Does Not Do
Common misunderstandings include:
- "Lyophilized means it lasts forever." Not true. Even after successful lyophilization, proteins in the solid state may still have limited long-term storage stability [3].
- "Freeze-drying sterilises the product." Freeze-drying removes water; it is not a sterilisation step. Sterility depends on controlled manufacturing and aseptic processing. See endotoxin and sterility testing.
- "A nice-looking cake means good quality." Appearance can hint at problems such as collapse, but it cannot confirm identity, purity or content. Those require laboratory testing, summarised on a Certificate of Analysis.
After Lyophilization: Storage Still Matters
A lyophilized peptide is typically sealed in a vial or container designed to keep moisture and air out. Peptides are often very hygroscopic, so once a container is opened, the powder can start absorbing water from the air [2]. Temperature and light also continue to matter. The EMA notes that peptides are generally stored refrigerated or frozen to prevent or minimise degradation [2].
For practical, science-based context, read our guide to peptide storage: temperature, light and moisture.
Frequently Asked Questions
What is the difference between lyophilization and freeze-drying?
There is no difference. They are two names for the same process.
Why is lyophilized peptide powder sometimes barely visible in a vial?
Many peptides are handled in very small amounts, and the dried cake can be light and porous. The volume of powder is not a reliable indicator of the amount of peptide present; only a content (assay) test can tell you that.
Is a lyophilized peptide completely dry?
No. Some residual moisture always remains after secondary drying. Manufacturers aim for a level that supports stability for that particular product [1][4].
Does lyophilization change the peptide?
It should not change the peptide's chemical structure if the process and formulation are well designed, but freezing and drying stresses can cause damage if they are not [3].
Can I tell if a lyophilized product has degraded by looking at it?
Not reliably. Visible changes may suggest a problem, but degradation such as oxidation or deamidation can only be confirmed by analytical testing.
References
- Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 2004;21(2):191-200. https://doi.org/10.1023/b:pham.0000016234.73023.75 ↗
- European Medicines Agency. Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025). https://www.ema.europa.eu/en/development-manufacture-synthetic-peptides-scientific-guideline ↗
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. https://doi.org/10.1016/s0378-5173(00)00423-3 ↗
- Chang LL, Shepherd D, Sun J, Tang XC, Pikal MJ. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies. J Pharm Sci. 2005;94(7):1445-1455. https://doi.org/10.1002/jps.20363 ↗
- Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schöneich C, Avanti C. Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: a review. Pharmaceutics. 2023;15(3):935. https://doi.org/10.3390/pharmaceutics15030935 ↗
- Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030. https://doi.org/10.1098/rsfs.2017.0030 ↗
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14(8):969-975. https://doi.org/10.1023/a:1012180707283 ↗
This article is for educational purposes only and is not medical advice. It does not provide instructions for preparing or using any product. For health decisions, consult a qualified healthcare professional, and for regulatory questions, consult the medicines regulator in your jurisdiction.